Valuation: Guided Therapeutics, Inc.

Market Cap 25.1M 22.08M 20.51M 18.86M 35.37M 2.43B 36.01M 245M 95.65M 1.19B 94.23M 92.19M 4.11B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 27.98M 24.6M 22.86M 21.02M 39.42M 2.71B 40.13M 273M 107M 1.32B 105M 103M 4.58B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 week-18.19%
Current month-4.58%
1 month-11.92%
3 months+14.50%
6 months-41.28%
Current year-57.59%
1 week 0.2
Extreme 0.2
0.28
1 month 0.2
Extreme 0.2
0.32
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 70 2016-11-30
Director/Board Member 76 2006-04-09
Chairman 67 2013-09-30
Date Insider Type Main position Quantity % Market Cap.
3/10/26 Others

Director

10 0.9747%
3/10/26 Free

Chairman

110,000 0.1316%
3/10/26 Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-18.19%-3.90%+68.26% 26.07M
+8.71%+5.36%+22.63%+1.80% 196B
+7.46%-6.10%-2.72%-24.77% 126B
-2.54%-17.48%-33.85%-1.38% 120B
+1.42%-2.33%-59.56%-18.02% 63.87B
-0.65%-4.58%+8.98%-9.45% 48.58B
-1.56%-3.21%-26.85%-33.72% 43.93B
+4.71%+2.67%+16.97%+9.50% 37.69B
+3.13%+1.12%+29.35%+32.45% 36.41B
+3.14%+3.47%+88.18%+3.34% 28.88B
Average +2.10%-3.03%+3.92%+2.80% 70.13B
Weighted average by Cap. +3.61%-5.06%-0.40%-6.25%

Financials

2024 2025
Net sales 7K 6.16K 5.72K 5.26K 9.86K 678K 10.04K 68.39K 26.68K 331K 26.28K 25.71K 1.15M 767K 675K 627K 576K 1.08M 74.28M 1.1M 7.49M 2.92M 36.23M 2.88M 2.82M 126M
Net income -2.42M -2.13M -1.97M -1.82M -3.41M -234M -3.47M -23.61M -9.21M -114M -9.07M -8.88M -396M -3.2M -2.81M -2.61M -2.4M -4.5M -310M -4.58M -31.23M -12.18M -151M -12M -11.74M -524M
Net Debt 1.77M 1.56M 1.45M 1.33M 2.5M 172M 2.54M 17.3M 6.75M 83.65M 6.65M 6.5M 290M 2.88M 2.53M 2.35M 2.16M 4.05M 279M 4.13M 28.1M 10.96M 136M 10.8M 10.56M 471M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-07-23 US$0.2600 -3.70% 5,100
26-07-22 US$0.2700 -0.47% 310
26-07-21 US$0.2713 -1.35% 5,500
26-07-20 US$0.2750 -1.75% 2,200
26-07-16 US$0.2799 +3.67% 573
  1. Stock Market
  2. Stocks
  3. GTHP Stock